Kelch-like ECH-associated protein 1 (KEAP1) is mutated in 17% of lung adenocarcinomas [8] and confers resistance to platinum therapy and immunotherapies [9,10,11]. The gene discussed is KEAP1; the disease is lung adenocarcinoma.